McNurlan et al., 1995 - Google Patents
Protein and amino acids in nutritional supportMcNurlan et al., 1995
- Document ID
- 11096996307996246059
- Author
- McNurlan M
- Garlick P
- Publication year
- Publication venue
- Critical care clinics
External Links
Snippet
This article discusses the role of amino acids in nutritional support during critical illness. The basis for assessing the requirements for protein and amino acids is presented, and the case for enhanced requirement of particular amino acids is discussed. Specific requirements for …
- 150000001413 amino acids 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Evoy et al. | Immunonutrition: the role of arginine | |
| Fürst | New developments in glutamine delivery | |
| Wilmore et al. | Role of glutamine in immunologic responses | |
| Jebb et al. | 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation | |
| USRE39705E1 (en) | Method of treating glutathione deficient mammals | |
| Tong et al. | Cellular and physiological effects of arginine | |
| CA2468133C (en) | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy | |
| Ziegler et al. | Potential role of glutamine supplementation in nutrition support | |
| US4957938A (en) | Nutritional formulation for the treatment of renal disease | |
| US6391332B1 (en) | Therapeutic micronutrient composition for severe trauma, burns and critical illness | |
| OKITA et al. | Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture | |
| CN108721596A (en) | A kind of compound amino acid vitamin injection and its application | |
| JPS61247354A (en) | Nutrinet composition | |
| JP4419390B2 (en) | Inflammatory disease treatment and prevention agent | |
| Dudrick et al. | Amino acids in surgical nutrition: Principles and practice | |
| US6797729B1 (en) | Therapeutic glutamine and N-actyl-cysteine composition | |
| WO2008095093A2 (en) | Method of increasing cellular function and health of glutathione deficient animals | |
| Lambert et al. | Net portal absorption of enterally fed α-ketoglutarate is limited in young pigs | |
| McNurlan et al. | Protein and amino acids in nutritional support | |
| CA2134380C (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man | |
| PT656178E (en) | NUTRITIONAL COMPOSITIONS FOR THE MANAGEMENT OF NITROGEN METABOLISM | |
| JP3914585B2 (en) | Macrophage nitric oxide production enhancer | |
| Leguina-Ruzzi et al. | Glutamine: a conditionally essential amino acid with multiple biological functions | |
| Ziegler et al. | Ornithine α‐Ketoglutarate and Glutamine Supplementation During Refeeding of Food‐Deprived Rats | |
| Gardiner et al. | Amino acids as specific therapy in human disease |